PATIENT FOCUSED MEDICINE Trademark

Trademark Overview


On Thursday, October 25, 2012, a trademark application was filed for PATIENT FOCUSED MEDICINE with the United States Patent and Trademark Office. The USPTO has given the PATIENT FOCUSED MEDICINE trademark a serial number of 85763460. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, March 9, 2024. This trademark is owned by Asepsis Pharmaceuticals Inc.. The PATIENT FOCUSED MEDICINE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of d...
patient focused medicine

General Information


Serial Number85763460
Word MarkPATIENT FOCUSED MEDICINE
Filing DateThursday, October 25, 2012
Status800 - REGISTERED AND RENEWED
Status DateSaturday, March 9, 2024
Registration Number4313188
Registration DateTuesday, April 2, 2013
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 15, 2013

Trademark Statements


Goods and ServicesAnti-infectives; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical products for ophthalmological use; Potassium preparations for pharmaceutical purposes
NOT AVAILABLE"MEDICINE"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 31, 2012
Primary Code005
First Use Anywhere DateSunday, August 1, 2010
First Use In Commerce DateSunday, August 1, 2010

Trademark Owner History


Party NameAsepsis Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSarasota, US 34234

Party NameAsepsis Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Stonington, US 06359

Party NameAsepsis Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Stonington, US 06359

Trademark Events


Event DateEvent Description
Monday, October 29, 2012NEW APPLICATION ENTERED
Wednesday, October 31, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 5, 2012ASSIGNED TO EXAMINER
Wednesday, December 5, 2012EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 5, 2012EXAMINERS AMENDMENT E-MAILED
Wednesday, December 5, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 5, 2012ASSIGNED TO LIE
Thursday, December 6, 2012EXAMINER'S AMENDMENT ENTERED
Thursday, December 6, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 13, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 26, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 15, 2013PUBLISHED FOR OPPOSITION
Tuesday, January 15, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 2, 2013REGISTERED-PRINCIPAL REGISTER
Monday, April 2, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, April 30, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, May 5, 2018TEAS SECTION 8 RECEIVED
Saturday, May 5, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 9, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 9, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, May 9, 2018NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Saturday, April 2, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, September 26, 2023TEAS SECTION 8 & 9 RECEIVED
Saturday, March 9, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, March 9, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, March 9, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, March 9, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED